Elastomeric Infusion Pumps Market Research Report 2025
Elastomeric Infusion Pumps Market Global Industry Analysis and Forecast (2025-2032) Product Type (Continuous Rate Elastomeric Pump and Variable Rate Elastomeric Infusion Pump), Application (Pain Management, Chemotherapy, Chelation Therapy, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Region
Elastomeric Infusion Pumps Market Synopsis:
Elastomeric Infusion Pumps Market Size Was Valued at USD 659.5 Million in 2024, and is Projected to Reach USD 1012.13 Million by 2032, Growing at a CAGR of 5.5% from 2025-2032.
The elastomeric infusion pumps market is experiencing robust growth due to the increasing demand for convenient, user-friendly, and affordable drug delivery systems in home and outpatient environments. The pumps, also referred to as balloon or ball pumps, provide a steady and controlled delivery of medication without electricity and gravity dependence and are particularly well-suited for chronic therapies such as chronic pain management, chemotherapy, and outpatient antibiotic therapy (OPAT).
This expansion in the market is driven by rising cancer rates, an expanding geriatric population, and increased demand for home-based care in order to mitigate hospital burden. Elastomeric pumps are also becoming popular for post-op pain management and in oncology environments because of their dependability, lower cross-contamination risk, and support for mobile lifestyles. New developments in healthcare in recent times include the East and North Hertfordshire elastomeric pump pathway and B. Braun's pre-configured IV systems, moreover, highlight the international trend towards effective, patient-focused infusion options.
Top Active Players Involved Are:
“Ace Medical Co., Ltd. (South Korea), Avanos Medical, Inc. (USA), B. Braun SE (Germany), Daiken Medical Co., Ltd. (Japan), Eitan Medical (Israel), Flowonix Medical Inc. (USA), Fresenius Kabi AG (Germany), Halyard Health (USA), Heka Healthcare (India), ICU Medical, Inc. (USA), Leventon, S.A.U. (Spain), Nipro Medical Corporation (Japan), Palex Medical SA (Spain), Pfizer Inc. (USA), Pfm Medical AG (Germany), Promecon Gmbh (Germany), Smiths Group plc (UK), Terumo Corporation (Japan), Westmed, Inc. (USA), Woo Young Medical Co., Ltd. (South Korea), Zyno Medical (USA), and Other Active Players.”
Elastomeric Infusion Pumps Market Growth and Trend Analysis:
Growth Driver Change Towards Home-Based Care
- The increased focus on home-based care is driving the elastomeric infusion pumps market to a great extent. Elastomeric pumps enable patients to be administered constant infusion therapy without being hospitalized, enhancing patient comfort and lowering healthcare expenditures.
- Especially beneficial in long-term diseases such as infections, cancer, or pain relief, elastomeric pumps are portable, simple to operate, and do not need electricity conditions under which they can be used at home. Interventions such as the Hospital at Home initiative in the UK complement this trend by facilitating early discharge and alleviating hospital workload. This trend is consistent with worldwide healthcare objectives of decentralizing treatment and enhancing accessibility.
Limiting Factor Limited Flow Rate Precision
- Elastomeric pumps, although uncomplicated and efficient, lack the precision required to maintain flow rates. Their drug delivery rate varies based on influences such as the ambient temperature, the vertical separation of the pump from the site of infusion, and the patient's backpressure.
- As contrasted to programmable electric pumps, the elastomeric variants do not feature real-time alarms or monitoring of flow aberrancies. Without the precision required in treatments like use in critical care or children's use, the lack of exactness here might be unacceptable for some drugs that need fixed doses. Consequently, their use is occasionally limited to situations in which minor flow deviations are acceptable from a clinical perspective.
Expansion Opportunity Increasing Demand in Cancer Care
- According to WHO Globally, there were an estimated 20 million new cases of cancer and 9.7 million deaths from cancer in 2022. The cancer burden will increase by about 77% by 2050. The growing worldwide incidence of cancer offers a compelling opportunity for elastomeric infusion pumps, particularly in ambulatory chemotherapy. By enabling patients to receive extended infusions like fluorouracil without requiring hospitalization, elastomeric pumps facilitate mobility and quality of life.
- Oncology patients are often in need of prolonged therapy that is aided by regular, sustained delivery of medication, which can be delivered by elastomeric pumps. Their disposable nature also lowers the chances of infection and cross-contamination. With healthcare systems focused on decreasing hospitalizations and enhancing outpatient treatment, elastomeric pumps are well suited to fill the increasing demand for cancer treatment regimens globally.
Challenge Barrier Patient Education and Compliance
- A key challenge in the elastomeric pump market is ensuring that patients and caregivers are properly educated on the pump’s usage and safety measures. Unlike hospital-administered therapies, home use requires individuals to understand how to check for flow issues, monitor for complications, and manage basic maintenance.
- Misuse or misunderstanding can lead to serious problems like incorrect dosing, delayed infusions, or infections. This is particularly important for low-literacy or elderly patients. Absent full training and guidance from care providers, the success of elastomeric therapy in outpatient settings can be undermined, possibly with consequences for treatment outcomes.
Elastomeric Infusion Pumps Market Segment Analysis:
Elastomeric Infusion Pumps Market is segmented based on Product type, Application, End-Users, and Region
By Product type, Continuous rate elastomeric pump Segment is Expected to Dominate the Market During the Forecast Period
- The continuous rate elastomeric pump segment will account for the maximum share in the global elastomeric infusion pumps market. Pumps are heavily favored because of their ease, reliability, and steady drug release over a stipulated duration of time, due to which these pumps are specifically suited for most common applications involving post-operative pain relief, chemotherapy, and outpatient antibiotic therapy.
- Their convenience, low setup needs, and compatibility with home care make them superior to variable rate pumps, which are complicated and need adjustment. With the increasing demand for low-maintenance and affordable infusion therapy, the continuous rate segment is expected to retain a market-leading position.
By Application, Pain Management Segment Held the Largest Share in 2024
- The pain management segment held the greatest market share of the elastomeric infusion pumps market. This is mainly due to the worldwide increase in chronic pain conditions like arthritis, neuropathy, and postoperative pain that necessitate steady and effective pain control.
- Elastomeric pumps provide continuous analgesic delivery, promoting patient comfort without dependence on hospital-based therapy. In addition, advances in technology like precision drug delivery devices and minimally invasive treatments are further increasing demand for advanced pain management devices, making elastomeric pumps a convenient, portable option in hospital and home care environments.
Elastomeric Infusion Pumps Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast Period
- North America was the most significant elastomeric infusion pumps market share in 2024. The region's dominance is due to the high demand for home healthcare services, along with the high prevalence of chronic illnesses. Additionally, the growing population of elderly individuals in the region is driving demand for infusion pumps, including elastomeric pumps. Demand for portable home healthcare services is also growing, which will positively influence market growth in the near future.
- In North America, the U.S. dominated the elastomeric infusion pumps market due to positive reimbursement policies, a robust healthcare infrastructure, and availability of key market players within the country. The FDA has also imposed stringent laws to ensure the safety and effectiveness of infusion pumps, which can lead to innovative products.
Elastomeric Infusion Pumps Market Active Players:
- Ace Medical Co., Ltd. (South Korea)
- Avanos Medical, Inc. (USA)
- Braun SE (Germany)
- Daiken Medical Co., Ltd. (Japan)
- Eitan Medical (Israel)
- Flowonix Medical Inc. (USA)
- Fresenius Kabi AG (Germany)
- Halyard Health (USA)
- Heka Healthcare (India)
- ICU Medical, Inc. (USA)
- Leventon, S.A.U. (Spain)
- Nipro Medical Corporation (Japan)
- Palex Medical SA (Spain)
- Pfizer Inc. (USA)
- Pfm Medical AG (Germany)
- Promecon Gmbh (Germany)
- Smiths Group plc (UK)
- Terumo Corporation (Japan)
- Westmed, Inc. (USA)
- Woo Young Medical Co., Ltd. (South Korea)
- Zyno Medical (USA)
- Other Active Players
Key Industry Developments in the Elastomeric Infusion Pumps Market:
- In March 2025, Braun Medical Inc. announced the launch of Cefazolin 3 g in its DUPLEX® Container, addressing the dosing needs of patients weighing 120 kg or more. The ready-to-use IV system simplified bedside administration, reduced preparation time, and minimized dosing errors for healthcare professionals.
- In January 2024, East and North Hertfordshire launched a new elastomeric pump pathway under the Hospital at Home programme to support earlier discharges and reduce hospital admissions. The pathway enabled patients on antibiotics or with heart failure to receive treatment at home with fewer nurse visits.
|
Elastomeric Infusion Pumps Market |
|||
|
Base Year: |
2024 |
Forecast Period: |
2025-2032 |
|
Historical Data: |
2018 to 2024 |
Market Size in 2024: |
USD 659.5 Mn. |
|
Forecast Period 2025-32 CAGR: |
5.5% |
Market Size in 2032: |
USD 1012.13 Mn. |
|
Segments Covered: |
By Product type |
|
|
|
By Application |
|
||
|
By End-User |
|
||
|
By Region |
|
||
|
Growth Driver: |
|
||
|
Limiting Factor |
|
||
|
Expansion Opportunity |
|
||
|
Challenge Barrier |
|
||
|
Companies Covered in the Report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Industry Ecosystem
3.4 Industry Value Chain Mapping
3.5 Strategic PESTLE Overview
3.6 Porter's Five Forces Framework
3.7 Regulatory Framework
3.8 Pricing Trend Analysis
3.9 Intellectual Property Review
3.10 Technology Evolution
3.11 Import-Export Analysis
3.12 Consumer Behavior Analysis
3.13 Investment Pocket Analysis
3.14 Go-To Market Strategy
Chapter 4: Elastomeric Infusion Pumps Market by Product Type (2018-2032)
4.1 Elastomeric Infusion Pumps Market Snapshot and
Frequently Asked Questions
What is the Forecast Period Covered in the Elastomeric Infusion Pumps Market Research Report?
The projected forecast period for the Elastomeric Infusion Pumps Market Research Report is 2025-2032.
Who are the Key Players in the Elastomeric Infusion Pumps Market?
Ace Medical Co., Ltd. (South Korea), Avanos Medical, Inc. (USA), B. Braun SE (Germany), Daiken Medical Co., Ltd. (Japan), Eitan Medical (Israel), Flowonix Medical Inc. (USA), Fresenius Kabi AG (Germany), Halyard Health (USA), Heka Healthcare (India), ICU Medical, Inc. (USA), Leventon, S.A.U. (Spain), Nipro Medical Corporation (Japan), Palex Medical SA (Spain), Pfizer Inc. (USA), Pfm Medical AG (Germany), Promecon Gmbh (Germany), Smiths Group plc (UK), Terumo Corporation (Japan), Westmed, Inc. (USA), Woo Young Medical Co., Ltd. (South Korea), Zyno Medical (USA), and Other Active Players.
How is the Elastomeric Infusion Pumps Market segmented?
The Elastomeric Infusion Pumps Market is segmented into Product type, Application, End-Users, and Region. By Product type, the market is categorized into Continuous Rate Elastomeric Pump and Variable Rate Elastomeric Infusion Pump. By Application, the market is categorized into Pain Management, Chemotherapy, Chelation Therapy, and Others. By End-Users, the market is categorized into Hospitals, Ambulatory Surgical Centers, and Others. By Region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Russia; Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; The Netherlands; Italy; ; Spain; Rest of Western Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC), Middle East & Africa (Türkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil; Argentina, etc.).
What defines the Elastomeric Infusion Pumps Market?
The elastomeric infusion pumps market is experiencing robust growth due to the increasing demand for convenient, user-friendly, and affordable drug delivery systems in home and outpatient environments.
What is the market size of the Elastomeric Infusion Pumps Market?
Elastomeric Infusion Pumps Market Size Was Valued at USD 659.5 Million in 2024, and is Projected to Reach USD 1012.13 Million by 2032, Growing at a CAGR of 5.5% from 2025-2032.
